December 19, 2013
Cell surface lipids hide molecular patterns that infection-killing cells might recognize as dangerous.
September 30, 2013
Three University of Washington faculty members are among those honored with a grant from the National Institutes of Health’s High Risk-High Reward program.
September 10, 2013
A combination of interferon-alpha 2b and ribavirin, drugs routinely given for hepatitis C, may be an effective treatment for the coronovirus that causes this new disease.
July 10, 2013
Funded by the NIH at $15 million over five years, the lab will be a national resource to evaluate candidate vaccines from studies around the country.